News
Dal and Nova Scotia Health launch new public health division
The new division is redefining public health training in the Maritimes, building academic capacity, advancing research, and preparing future leaders. Read more.
Featured News
Friday, March 6, 2026
Each year, Dalhousie celebrates outstanding individuals — from community and business leaders to artists, scientists and scholars — with the presentation of an honorary doctorate. And every one of those moments begins with a nomination.
Saturday, February 28, 2026
A new collaboration with IIT Tirupati and IISER Tirupati will unite researchers, learners, and industry partners to accelerate innovation and expand economic opportunities between India and Canada.
Thursday, February 19, 2026
Dalhousie launches new online, course-based master’s program designed to equip licensed clinicians with advanced psychiatric training as communities worldwide face growing gaps in mental health services.
Archives - News
Thursday, November 19, 2020
Master of Engineering student Arad Gharagozli, founder and president of Dalhousie’s Space Systems Lab and CEO of GALAXIA Mission Systems, explains how SpaceX is changing the future of space exploration.
Tuesday, November 17, 2020
Marsha Campbell-Yeo, a professor in Dal's School of Nursing, has undertaken a study looking into how families have coped with the new rules in Neonatal Intensive Care Units across Canada.
Monday, November 16, 2020
With the U.S. election now over and president-elect Joe Biden trying to create an orderly transition plan amid continued false accusations of election fraud from President Donald Trump, panelists from a Dal-hosted Open Dialogue event last month have returned to share their reactions.
Friday, November 13, 2020
Following the tragic shooting rampage that cost the lives of 23 Nova Scotians in April, Adrian Delli Colli and Ireland Thurler were spurred to action — walking from Portapique to Enfield to raise money they now plan to use to create a scholarship fund for the victim's families.
Friday, November 13, 2020
Drugmaker Pfizer's news this week that its experimental vaccine is more than 90 percent effective in preventing COVID-19 was met with much jubilance. Dr. Scott Halperin, a professor in the Division of Infectious Diseases, explains what comes next in Pfizer's large-scale clinical trial, how significant a 90 percent efficacy rate is, and how vaccines will be distributed.